Atherogenesis inhibition by darapladib administration in dyslipidemia model SpragueDawley rats

Background: Atherosclerosis is a chronic inflammation disease that is caused by the interaction between monocyte and endothelial injury in tunica intima. One of the major factor of atherosclerosis is dyslipidemia. Chronic dyslipidemia, especially hypercholesterolemia, can directly alter endothelial...

Cijeli opis

Bibliografski detalji

Glavni autori:	Teuku Heriansyah, Titin Andri Wihastuti, Kenty Wantri Anita, Agustin Iskandar, Riski Bagus Suhendra, Patan Ahmad Setiabudi, Lintang Widya Sishartami
Format:	Artigo
Jezik:	Inglês
Izdano:	Eldaghayes Publisher 2016-01-01
Serija:	National Journal of Physiology, Pharmacy and Pharmacology
Teme:	darapladib; lp-pla2; ox-ldl; foam cell; pvat; dyslipidemia
Online pristup:	http://www.ejmanager.com/fulltextpdf.php?mno=203195
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!